Is CytoMed Therapeutics Limited (GDTC) a Buy, Sell, or Hold?
NASDAQ : GDTC
CytoMed Therapeutics Limited — Competitors
$0.865 USD
-$0.12 (-12.63%)
- Volume
- 169.18K
- Average Volume
- 18.89K
- Market Capitalization
- $10.24M
- P/E Ratio
- -2.76
- Dividend Yield
- 0.00%
- Price Target
- Year High
- $3.68
- Year Low
- $0.68
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $5.17
GDTC vs. The Competition
| Properties | GDTC | CLGN | ENLV | LSTA |
|---|---|---|---|---|
| Market Cap | $10.24M | $4.25M | $70.53M | $13.48M |
| Shares Outstanding | $11.83M | $12.97M | $16.83M | $9.11M |
| P/E Ratio | -2.76 | -0.32 | 0.01 | -0.8 |
| EPS | -0.41 | -0.96 | 407.81 | -1.82 |
| Day Low | 0.85 | 0.312 | 4.02 | 1.43 |
| Day High | 0.948 | 0.344 | 4.32 | 1.6 |
| Year Low | 0.68 | 0.271 | 4.02 | 1.43 |
| Year High | 3.68 | 3.232 | 31.5 | 5.07 |
| Average Price 50 | 1.06524 | 0.36894 | 8.948 | 3.2814 |
| Average Price 200 | 1.30583 | 1.06278 | 13.37765 | 3.28925 |
| Volume | 169.18K | 12513 | 34523 | 71929 |
| Average Volume | - | - | - | - |